VIP Industries closed Q4FY25 with a mixed bag. While volumes saw healthy growth, operational performance remained underwhelming. The company has acknowledged the drag and is gearing up to pivot—with a sharper focus on digital, modern trade, and brand revival.

Kalpataru Projects (KPIL) has just announced its Q4FY25 earnings, and the numbers look quite promising. In fact, the company’s performance came in ahead of expectations, signaling continued momentum in the business. Let’s break down the key highlights and what investors can expect going forward.

Explore the rise of Makhana as India’s next big food export, supported by startups, state backing, and surging global demand.

Raising capital to support expansion, reduce debt, or strengthen operations is a core objective for many publicly listed companies in India.

Benchmark indices experienced profit booking at higher levels. The Nifty closed 74 points lower, while the Sensex fell by 271 points. Among the sectors, the real estate index outperformed, gaining over 2%, while the digital index suffered the most, closing approximately 1.5% lower.

Suppose you are an entrepreneur, evaluating two potential projects: one involves launching a new line of eco-friendly home products, and the other focuses on expanding your existing retail store.

Global Health (Medanta) continues to inspire confidence as it delivers a strong show in Q4FY25. The hospital chain has seen commendable results across both mature and new facilities, setting the tone for growth over the coming years.

Let’s talk about Eureka Forbes Limited (EFL)—you know, the company that probably sold you your first water purifier. Well, they’re not just keeping homes clean anymore—they’re also keeping investors smiling with another impressive financial quarter.

Discover what’s driving the rise of India’s toy industry and key trends in the market.

If you’ve been keeping an eye on Piramal Pharma, here’s a quick lowdown on how they performed in Q4FY25 and what it means going forward.